Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

OncoMed and Bayer select small-molecule Wnt pathway inhibitor for preclinical development

Oct. 3, 2014

Pfizer and Kyowa Hakko Kirin to collaborate on immuno-oncology combination trial

Oct. 3, 2014

Helix BioPharma reports interim data from phase I/II trial of L-DOS-47

Oct. 2, 2014

Bristol-Myers Squibb provides milestone update for Opdivo

Sep. 30, 2014

EMA committee recommends European approval of Cyramza

Sep. 29, 2014

FDA grants orphan drug status to IMM-101 for pancreatic cancer

Sep. 26, 2014

FDA grants orphan drug designation to MabVax Therapeutics' neuroblastoma vaccine

Sep. 26, 2014

Amgen submits BLA for BiTE immunotherapy blinatumomab

Sep. 23, 2014

Kancera updates on drugs and vaccines targeting ROR1

Sep. 23, 2014

TapImmune reports interim data from phase I trial of folate receptor alpha antigens

Sep. 18, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...